Yorktown Management & Research CO Inc Bristol Myers Squibb CO Transaction History

Yorktown Management & Research CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $210,765 - $245,703	-3,930 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $148,350 - $166,850	-2,500 Reduced 38.88%	3,930 $248,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $46,769 - $52,998	810 Added 14.41%	6,430 $399,000
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $24,120 - $26,728	420 Added 8.08%	5,620 $339,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $465,970 - $544,765	-8,500 Reduced 62.04%	5,200 $306,000
Q1 2020 Apr 29, 2020	BUY	$46.4 - $67.43 $13,920 - $20,229	300 Added 2.24%	13,700 $764,000
Q3 2019 Nov 01, 2019	BUY	$42.77 - $50.71 $573,118 - $679,514	13,400 New	13,400 $680,000
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $902,400 - $1.08 Million	-20,000 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$55.19 - $62.25 $883,040 - $996,000	16,000 Added 400.0%	20,000 $1.24 Million
Q2 2018 Aug 10, 2018	BUY	$50.53 - $62.98 $202,120 - $251,920	4,000 New	4,000 $221,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

Stay updated on Yorktown Management & Research CO Inc with notifications on news.